KA
CSTM icon

Kailix Advisors’s Constellium CSTM Stock Holding History

Kailix Advisors’s Portfolio CSTM Stock Details CSTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$13.5M Sell
494,400
-483,657
-49% -$11.5M 11.83% 3
2025
Q4 		$18.4M Sell
978,057
-125,112
-11% -$2.08M 20.55% 1
2025
Q3 		$16.4M Sell
1,103,169
-129,150
-10% -$1.85M 22.34% 1
2025
Q2 		$16.4M Sell
1,232,319
-501,000
-29% -$5.63M 25.38% 1
2025
Q1 		$17.5M Sell
1,733,319
-351,868
-17% -$3.74M 19.65% 1
2024
Q4 		$21.4M Buy
2,085,187
+424,779
+26% +$5.22M 17.95% 2
2024
Q3 		$27M Buy
1,660,408
+213,763
+15% +$3.63M 22.76% 2
2024
Q2 		$29.2M Buy
1,446,645
+413,605
+40% +$8.6M 18.38% 2
2024
Q1 		$22.8M Buy
1,033,040
+36,013
+4% +$697K 13.36% 3
2023
Q4 		$19.9M Sell
997,027
-174,188
-15% -$3.05M 11.16% 4
2023
Q3 		$21.3M Buy
1,171,215
+301,500
+35% +$5.32M 10.32% 4
2023
Q2 		$15M Buy
869,715
+178,169
+26% +$2.73M 8.3% 4
2023
Q1 		$10.6M Sell
691,546
-602,463
-47% -$8.77M 7.37% 6
2022
Q4 		$15.3M Buy
+1,294,009
New +$15.1M 9.43% 5

Other funds holding CSTM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
B
Bpifrance Maisons Alfort, Cedex, France $1.65B AUM 19.85% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Kailix Advisors's CSTM Position: Q1 2026 in Review

Kailix Advisors reduced its Constellium (CSTM) stake by 49% in Q1 2026, selling an estimated $11.5M and leaving 494,400 shares worth $13.5M. The position accounts for 11.83% of the portfolio, ranked #3.

Kailix Advisors first reported a position in CSTM in Q4 2022 and has held it in 14 quarters since. The position peaked at $29.2M in Q2 2024. 313 funds tracked by Wall St. Rank hold CSTM as of Q1 2026.

  • Kailix Advisors held 494,400 shares of Constellium worth $13.5M as of Q1 2026.
  • Kailix Advisors sold 483,657 Constellium shares in Q1 2026, an estimated $11.5M.
  • Constellium made up 11.83% of Kailix Advisors's portfolio in Q1 2026, its #3 holding.
  • Kailix Advisors first reported a position in Constellium in Q4 2022 and has held it in 14 quarters since.
  • Kailix Advisors's Constellium position peaked at $29.2M in Q2 2024.
  • 313 funds tracked by Wall St. Rank held Constellium as of Q1 2026.

Based on Kailix Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.